Hello, everyone. My name is Mitchell Kapoor. I'm a senior biotech analyst at H.C. Wainwright and the covering analyst for Lyell. Today, I have the pleasure of welcoming Lynn Seely, the CEO of the ...
TORONTO, May 14, 2026 /PRNewswire/ - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company advancing anti-inflammatory and anti-fibrotic ...
Participants may access a live webcast of the event by clicking the link here. The webcast can also be accessed in the Investors/Presentations & Events section of the Verrica website at ...
SAN MATEO, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic ...
Silence Therapeutics plc (Nasdaq: SLN), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today announced that Curtis Rambaran, MD, Chief Medical Officer of ...
Interested parties can access the live webcast for this conference from the Investor Relations section of the company's website at www.ranitherapeutics.com. The webcast replay will be available after ...
THE WOODLANDS, Texas, May 12, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the 4th Annual H.C.
BioConnect has introduced BioConnect Enterprise, a biometric identity platform designed to integrate directly with leading physical access control systems (PACS) and enhance physical security without ...
ZEELAND, MI — Gentex said it has acquired Toronto-based authentication software company BioConnect for $13 million. The deal, announced earlier this week, comes as Gentex as it continues to grow its ...
(RTTNews) - Gentex Corporation(GNTX), an electronic products maker, said on Monday that it has acquired BioConnect, a Canadian biometric authentication solutions company. Neil Boehm, Chief Technology ...
(MENAFN- GlobeNewsWire - Nasdaq) ZEELAND, Mich., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Gentex Corporation (NASDAQ: GNTX ) announced today that it has acquired Toronto-based BioConnect, a leader in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results